Amag Pharmaceuticals (AMAG) says it received an unsolicited $381M buyout offer from MSMB Capital...

|By:, SA News Editor

Amag Pharmaceuticals (AMAG) says it received an unsolicited $381M buyout offer from MSMB Capital Management. The $18/share all-cash offer represents a 25% premium over Tuesday's closing price. A deal would scuttle Amag's planned buyout of Allos Therapeutics (ALTH); Amag shares have lost 25% since the Allos buyout was announced two weeks ago. AMAG +11.2% premarket.